Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124632352 | 12463235 | 2 | F | 20160714 | 20160614 | 20160721 | EXP | GB-MHRA-ADR 23492222 | GB-ACCORD-041391 | ACCORD | 14.00 | YR | F | Y | 0.00000 | 20160721 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124632352 | 12463235 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | DOSE SLOWLY INCREASED TO 150 MG DAILY | 202825 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124632352 | 12463235 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124632352 | 12463235 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124632352 | 12463235 | Abnormal weight gain | |
| 124632352 | 12463235 | Amenorrhoea | |
| 124632352 | 12463235 | Asthenia | |
| 124632352 | 12463235 | Blindness | |
| 124632352 | 12463235 | Dizziness | |
| 124632352 | 12463235 | Neurological symptom | |
| 124632352 | 12463235 | Sensory loss | |
| 124632352 | 12463235 | Strabismus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124632352 | 12463235 | 1 | 201512 | 0 |